Advanced Enzyme Technologies Shareholding Pattern
- Market cap
- ₹3,041 crore
- P/E
- 18.3
- P/B
- 1.86
- ROE
- 11.1%
- Dividend yield
- 0.50%
As of 30-JUN-2026, promoters held 43.24% of Advanced Enzyme Technologies (-0.02 pp from 31-MAR-2026), foreign institutional investors 26.71%, domestic institutions 4.78% and the public 25.27%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Advanced Enzyme Technologies shareholding pattern — frequently asked questions
What is the promoter holding in Advanced Enzyme Technologies?
Promoters held 43.24% of Advanced Enzyme Technologies as of 30-JUN-2026, down 0.02 pp from 43.26% in 31-MAR-2026.
How much do FIIs hold in Advanced Enzyme Technologies?
Foreign institutional investors held 26.71% of Advanced Enzyme Technologies as of 30-JUN-2026, a change of +1.22 pp from the previous quarter.
How much do domestic institutions hold in Advanced Enzyme Technologies?
Domestic institutional investors, including mutual funds and insurers, held 4.78% of Advanced Enzyme Technologies as of 30-JUN-2026 (-0.63 pp from the previous quarter).
Who owns Advanced Enzyme Technologies?
As of 30-JUN-2026, Advanced Enzyme Technologies' shareholders were promoters (43.24%), foreign institutional investors 26.71%, domestic institutions 4.78% and the public 25.27%, as filed with the stock exchanges.
Same Data For Peers
- Sun Pharmaceutical Industries Limited shareholding pattern
- Divi's Laboratories Limited shareholding pattern
- Torrent Pharmaceuticals Limited shareholding pattern
- Zydus Lifesciences Limited shareholding pattern
- Apollo Hospitals Enterprise Limited shareholding pattern
- Laurus Labs Limited shareholding pattern
Trade Advanced Enzyme Technologies With ATS
Track ADVENZYMES live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.